| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6005805 | Brain Stimulation | 2016 | 26 Pages |
Abstract
Despite small patient numbers, we conclude that DBS for GTS is a valid option for medically intractable patients. Different brain targets resulted in comparable improvement rates, indicating a modulation of a common network. Future studies might focus on a better characterization of the clinical effects of distinct regions, rather than searching for a unique target.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Juan Carlos Baldermann, Thomas Schüller, Daniel Huys, Ingrid Becker, Lars Timmermann, Frank Jessen, Veerle Visser-Vandewalle, Jens Kuhn,